GlassScriptPhysician profile
Viktoriya Nelson
NPI 1619093143
$988.19
in general payments reported to CMS, 2019-2025
15 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $19.03 · 2022: $98.02 · 2023: $259 · 2024: $209 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.67 | 2023-2025 | |
| Lilly USA, LLC | $145.33 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $131.76 | 2022-2024 | Rybelsus, Ozempic |
| Corcept Therapeutics | $116.45 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $74.26 | 2019-2022 | |
| Glaxosmithkline, LLC. | $39.94 | 2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $38.03 | 2024-2025 | Breztri, Airsupra |
| Pfizer INC. | $34.61 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.03 | 2019-2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $26.70 | 2025 | Rexulti |
| Mannkind Corporation | $19.89 | 2019 | |
| Exact Sciences Corporation | $19.74 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.07 | 2019 | |
| Axsome Therapeutics, INC. | $9.98 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viktoriya Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.